Insider Buying: Phillip Md Et Al Frost Buys 14,000 Shares of Opko Health Stock (OPK)
Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost purchased 14,000 shares of the stock on the open market in a transaction that occurred on Tuesday, January 7th. The shares were purchased at an average price of $8.47 per share, with a total value of $118,580.00. Following the completion of the transaction, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $16,834,125. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Opko Health (NYSE:OPK) traded up 1.56% on Wednesday, hitting $8.48. 2,497,461 shares of the company’s stock traded hands. Opko Health has a 52 week low of $5.08 and a 52 week high of $12.95. The stock’s 50-day moving average is $9.56 and its 200-day moving average is $8.97. The company’s market cap is $3.460 billion.
Several analysts have recently commented on the stock. Analysts at Barrington Research raised their price target on shares of Opko Health to $11.00 in a research note to investors on Friday, December 20th. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Opko Health in a research note to investors on Wednesday, December 18th. Finally, analysts at Jefferies Group raised their price target on shares of Opko Health from $10.00 to $11.50 in a research note to investors on Wednesday, November 13th. They now have a “buy” rating on the stock.
OPKO Health, Inc (NYSE:OPK), incorporated in October 1991, is a multi-national pharmaceutical and diagnostics company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.